Select your preferred language.

Choisissez votre langue préférée

Tuesday, April 5, 2016

Label expansion for Stratego PRO helps growers maximize their profits by fighting devastating diseases in corn and spring cereals

Already a trusted fungicide for soybeans and winter wheat, the new registration delivers exceptional and long-lasting control of diseases, providing higher yields and improved quality.

Guelph, ON (April 5, 2016) – Bayer announces the registration to extend the Stratego® PRO fungicide label for corn and spring cereals in eastern Canada. The fungicide is registered in corn for early control against key leaf diseases, including Northern corn leaf blight. It can be applied as a preventive disease control measure, or at the early stages of disease development.

“Thanks to the powerful addition of prothioconazole, Stratego PRO is already a trusted market leader in systemic fungicides for winter wheat and soybean growers,” said Christopher Turcot, Portfolio Manager, Row Crop, at Bayer CropScience Inc. “The new label expansion means this valuable tool is now able to deliver higher yields and greater profits to growers, by providing first-class disease protection across a larger variety of crops, including corn and spring wheat.”

The broad-spectrum fungicide delivers exceptional disease control through two modes of action: Group 3 (prothioconazole) and Group 11 (trifloxystrobin). On spring cereals, Stratego PRO provides control of septoria leaf blotch, powdery mildew, tan spot, and leaf, stem and stripe rust. On corn, the fungicide provides control of northern corn leaf blight, grey leaf spot, eye spot and common rust.

Through field testing conducted between 2013-2015, Stratego PRO demonstrated that by effectively controlling labeled diseases under a wide range of disease pressures, the fungicide delivered an average of 6.2 per cent yield increase in corn (vs. untreated), making it a cost effective decision for growers. For control of labelled leaf diseases, corn growers should apply Stratego PRO between 7-leaf and early tassel, or at the onset of disease presence.

Stratego PRO is registered for ground and aerial application. In addition to corn and spring cereals, Stratego PRO is now also registered for use on durum wheat, barley, oats, rye, triticale, millet, dry peas, lentils and chickpeas.


For more information regarding Stratego PRO, growers are encouraged to talk to their local retailers, visit, or follow @Bayer4CropsCA on Twitter.

– 30 –

Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to


Note to editors:

Print-quality photos can be downloaded from our website at

TV and multimedia editors can download or order updated film footage about Bayer free of charge at


Chris Turcot
Portfolio Manager, Row Crop
Bayer CropScience Inc.

Derrick Rozdeba
Vice President, Communications
Bayer Inc., Canada
Phone: 403-723-7432

Jackie Elliott
Account Supervisor
Weber Shandwick Canada
Phone: 416-642-7899

Forward-Looking Statements
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.